DAA1003 |
Wrinkles |
— |
skin |
Human |
|
DAA884 |
Widespread degeneration of glomerular blood vessels |
— |
renal vasculature |
Human |
|
DAA730 |
White matter volume decreases |
— |
white matter |
Human |
|
DAA826 |
Weaker digestive tract muscle contractions |
— |
alimentary system, smooth muscle |
Human |
|
DAA846 |
Weakening of intestinal wall |
— |
large intestine |
Human |
|
DAA703 |
Wall increases in thickness |
— |
left ventricle |
Human |
|
DAA948 |
Volume of perivascular space around thymus increases |
— |
thymus |
Human |
|
DAA936 |
Volume of hematopoietic bone marrow decreases |
— |
bone marrow |
Human |
|
DAA1947 |
Vitamin C levels decrease |
— |
blood, T cell |
Mouse |
|
DAA2583 |
Vision loss |
— |
visual apparatus |
Human |
|
DAA788 |
Viscoelastic modulus of brain tissue decreases |
— |
brain |
Human |
|
DAA794 |
Ventilatory rate at maximum exertion decreases |
— |
lung |
Human |
|
DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
— |
renal vasculature |
Human |
|
DAA2044 |
Variations in fat mass |
— |
adipose tissue |
Human |
|
DAA2043 |
Variations in body weight |
— |
whole body |
Human |
|
DAA1061 |
Variability in clearance of hepatically metabolized drugs |
— |
liver |
Human |
|
DAA966 |
Vaccination antibody response is impaired |
— |
immune system |
Human |
|
DAA900 |
Urine concentrating capacity decreases |
— |
renal tubule |
Human |
|
DAA699 |
Triglyceride levels increase |
— |
plasma |
Human |
|
DAA904 |
Transport maximum for glucose declines |
— |
renal tubule |
Human |
|
DAA2030 |
Transmission of visible light through eye lenses decreases |
— |
lens |
Human |
|
DAA2024 |
Total body water decreases |
— |
whole body |
Human |
|
DAA2048 |
Total body potassium declines |
— |
whole body |
Human |
|
DAA945 |
Thymus involution |
— |
thymus |
Human |
|
DAA946 |
Thymic hormone levels decrease |
— |
plasma |
Human |
|